Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restrictive versus liberal packed red blood cell transfusion threshold in very low birth weight premature neonates with respiratory distress syndrome
IRCT20120728010430N16Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2024
- Modality
- Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of red blood cells in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Duration of oxygen supplementation, Relative frequency of intraventricular hemorrhage and 3 more. Started Oct 2024; status: completed.
02
Drugs
red blood cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on IRCT20120728010430N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120728010430N16.